Guardian Pharmacy Business Model Canvas

Integrations with EMAR and EHR platforms enable e-prescribing and real-time MAR updates, supporting workflows that industry data show can cut medication administration errors by up to 50% and speed charting. Interface partnerships reduce transcription errors and latency, while joint product roadmaps deliver LTC-specific features (med pass scheduling, dose verification) and co-support models can halve mean time to resolution in practice.

Strategic partnerships with SNF/AL operators cut admission/transfer/discharge medication errors up to 40% (2024 pilots) and lowered ADEs 12%. National wholesalers supply ~85% of drugs; PBMs control ~80% of pharmacy benefits (2024). Accreditation/credentialing >90% for Medicare-contracted pharmacies supports payer access and compliance.

Building and maintaining HL7/FHIR interfaces connects prescribers, facilities and Guardian Pharmacy into a single workflow; by 2024 FHIR had become the industry standard for API-based exchange under ONC rules. Automated order intake cuts manual entry and pharmacy labor bottlenecks, while real-time status updates improve transparency and patient safety. Rigorous change control and versioning preserve data integrity across integrations.

High-accuracy filling with barcode verification achieves >99.9% accuracy while processing ~3,000–5,000 prescriptions weekly. Pharmacist MTM and drug regimen reviews record ≈3,500 interventions annually (2024). Logistics deliver 95% on-time first deliveries and STAT meds <30 minutes; training completion hit 98% in 2024.

Integrated dispensing software, EMAR integrations and analytics platforms power operations, with Surescripts-style e-prescribe connectivity now handling ~95% of prescriptions and real‑time analytics enabling sub‑2s dashboard latency and 99.9% availability. E-prescribe, barcode scanning and eMAR programs cut medication administration and dispensing errors by an estimated 50–80% in clinical studies. Role‑based access, AES encryption, MFA and HIPAA/SOC2 controls protect PHI.

Consultant pharmacists and certified techs deliver MTM and monthly CMS reviews; automation (2024) cut dispensing errors ~70% and raised throughput 30–50%. Decentralized pharmacies + 120-vehicle fleet sustain >95% on-time delivery; PBM contracts cover ~80% of scripts (2024). Secure IT/DEA/state licenses, AES/MFA/HIPAA controls ensure compliance and 99.9% system availability.

Regular pharmacist regimen reviews cut adverse drug events and 30-day readmissions through reconciliation and deprescribing, with programs benchmarking ADEs per 1,000 resident-days and readmission rates. CDC estimates antibiotic stewardship reduces inappropriate antibiotic use by 20–50%, and Guardian’s stewardship tracks days of therapy and resistance trends. Psychotropic oversight aligns with CMS guidance and has supported the sector-wide ~38% decline in antipsychotic prevalence since 2011, with dashboards showing measurable KPI improvements in 2024.

Guardian reduces med administration errors ~50% via BCMA/EMAR and unit-dose, cuts drug spend 10–25% through formulary/GPO strategies, and speeds order-to-administration ~30% with 95% EHR interoperability in 2024, driving 5–10% pharmacy spend savings and measurable KPI improvements.

Round-the-clock pharmacists handle urgent orders from clinicians and patients, supporting a STAT delivery service that achieved a 98% on-time fulfillment rate within 2 hours in 2024. After-hours deliveries cover critical needs with dedicated courier routing and real-time tracking. A hotline and secure messaging platform deliver 24/7 access, averaging under 60 seconds to first response and 92% resolution at first contact. All incidents are logged and trended, cutting repeat issues by 27% year-over-year.

Each facility has an account manager and clinical lead; 2024 metrics show 92% facility retention and 35% faster issue resolution. Weekly clinical touchpoints, QBRs and SLAs (24h/48h) drove 20% fewer delivery breaches YoY and an 18% drop in medication-related readmissions. Pilots and co-development accelerated adoption by 12% and delivered client ROI within 9 months.

Conferences and trade shows reach thousands of LTC decision-makers (typical event attendance 2,500–5,000) and speaking slots boost lead conversion by about 30% for speaker-led sessions. Booth demos highlighting EMAR integrations show workflow gains and can cut medication administration errors up to 25%. Around 40% of channel partnerships are initiated in-person according to 2024 channel-sales studies.

Regional sales use consultative demos yielding clinical ROI (up to 30% readmission reduction) and typical payback 6–12 months; targeted outreach drives 3x admin/clinician responses and website/webinars generated 40% of inbound leads in 2024. CRM provides 45% funnel visibility, virtual demos cut sales cycles 27%, procurement win rates ~25–30% for multi-site RFPs.

Memory care units serving the estimated 6.7 million Americans 65+ with Alzheimer disease in 2024 require adherence-friendly packaging to reduce missed doses, rigorous psychotropic monitoring to limit inappropriate prescribing, close care-team coordination for behavioral symptom management, and strict safety protocols to lower wandering and dosing risks.

Skilled nursing (≈15,600 facilities in 2024) needs 24–48h turnaround, high-acuity med management; Medicaid/Medicare (~62% nursing home funding) dominate. Assisted living (median cost $4,500/mo in 2024) needs simplified packaging, EMAR integration and caregiver training (≈50% turnover in 2023). Memory care (≈6.7M 65+ with Alzheimer in 2024) requires adherence-friendly packaging and psychotropic oversight. Hospice/post-acute (1.63M Medicare hospice users in 2022) needs rapid access to comfort kits.

Recurring costs include SaaS licenses, interfaces and cybersecurity monitoring (healthcare breach costs remain high; IBM reported ~10.1M USD average for healthcare breaches in 2023), while development and maintenance drive uptime SLAs. Hardware for automated dispensing (typical market range 50,000–200,000 USD) and barcode scanners (150–500 USD) is required. Cloud storage/backups add ~0.023 USD/GB-month on AWS S3 (2024) plus backup egress and retention overhead.

Medication spend (70–85% revenue) and specialty drugs (~50% of spend) dominate costs; labor (pharmacists ~$128k, techs ~$36k) and logistics ($6–8/delivery, cold chain +15–25%) are next largest. CAPEX: automated dispensing $50–200k; compliance $5–20k/year; insurance $1.5–5k.

Facility contracts typically charge per-resident per-month fees — industry average in 2024 about $45 PRPM for comprehensive services — with SLAs tying up to 10% of payments to metrics like fill accuracy and on-time delivery. Bundles commonly include scheduled delivery and returns processing. Multi-site deals often cut PRPM by 12–18% through scale.

Per-script gross in 2024 averaged $50–60 for Medicare Part D (60–70% of scripts), Medicaid ~30–40% below Part D and commercial 15–40% above; DIR/network fees trimmed net 10–30% and higher generic mix boosts margin. Facility PRPM averaged $45 (2024) with multi-site volume discounts of 12–18% and SLAs holding ~10% to performance. MTM/regimen fees $25–$100 monthly; STAT deliveries $12–$35 (+25–45% urgency).